Immunocore Holdings plc
Price
FilingsNewest: 8-K, Regulation FD disclosureSep 14 →InsidersNo open-market buys. 4 insiders sold $5.6M, 6 of 10 sales on a 10b5-1 plan.→HoldersWellington Management Group LLP 11.1%RTW Investments 9.5%FMR 8.4%→PeersClosest companies: TNGX, SYRE, RLAY→
From the filings
Figures
- Revenue
- $430.8Mlast 12 months
- Net income
- −$18.1Mlast 12 months
- Operating cash flow
- −$24.9Mlast 12 months
- Cash and equivalents
- $484.9Mat the last balance sheet
- Shares outstanding
- 51.5M shareson issue